This content is machine translated SGLT2i for heart failure HF prevalence in diabetes patients is underestimated in everyday clinical practice SGLT2 inhibitors can significantly reduce the risk of hospitalization for heart failure (HF) and death from cardiovascular causes in patients with diabetes and HF. However, the diagnosis of HF is…
View Post 2 min This content is machine translated Heart failure Novel approach leads to improvement in myocardial and vascular function In 2021, the European Society of Cardiology’s Heart Failure Guidelines Task Force published new guidelines mentioning heart failure exacerbations for the first time and emphasizing the urgency of accelerating the…
